Peak Bio Inc (PKBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2023 | 12-2022 | 12-2021 | 12-2020 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -12,826 | -13,089 | -8,293 | 0 | N/A |
| Depreciation Amortization | 311 | 787 | 177 | N/A | N/A |
| Accounts payable and accrued liabilities | 2,235 | 816 | -427 | N/A | N/A |
| Other Working Capital | 3,660 | 2,370 | 93 | N/A | N/A |
| Other Operating Activity | 1,862 | 1,631 | -414 | 0 | 0 |
| Operating Cash Flow | $-4,758 | $-7,486 | $-8,864 | $0 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -142 | -10 | N/A | N/A |
| Investing Cash Flow | $0 | $-142 | $-10 | $0 | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 4,368 | 1,600 | 1,500 | 80 | N/A |
| Debt Issued | N/A | N/A | 492 | N/A | N/A |
| Common Stock Issued | 1,135 | 5,177 | N/A | N/A | N/A |
| Other Financing Activity | -1,222 | 1,358 | 6,393 | -55 | 0 |
| Financing Cash Flow | $4,281 | $8,135 | $8,385 | $25 | $N/A |
| Exchange Rate Effect | 24 | -55 | 522 | N/A | N/A |
| Beginning Cash Position | 895 | 443 | 410 | 0 | N/A |
| End Cash Position | 442 | 895 | 443 | 25 | N/A |
| Net Cash Flow | $-453 | $452 | $33 | $25 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,758 | -7,486 | -8,864 | 0 | N/A |
| Capital Expenditure | 0 | -142 | -10 | N/A | N/A |
| Free Cash Flow | -4,758 | -7,628 | -8,874 | 0 | 0 |